Risk Factors for Hepatocellular Carcinoma

1. Bosch FX, Ribes J, Cleries R, Diaz M. Epidemiology of hepatocellular carcinoma.Clin Liver Dis 2005;9;191-21110.1016/j.cld.2004.12.00915831268Search in Google Scholar

2. El-Serag HB, Davila JA. Petersen NJ, McGlynn KA. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.Amn Intern Med 2003; 139:817-82310.7326/0003-4819-139-10-200311180-0000914623619Search in Google Scholar

3. Bruix J, Sherman M. Management of hepatocellular carcinoma.Hepatology 2005; 42;1208-12361625005110.1002/hep.2093316250051Search in Google Scholar

4. Mazzaranti R, Gramantieri L, Bolondi L. Hepatocellulr carcinima epidemiology and clinical aspects. Mod aspects Med 2008; 29:130-14310.1016/j.mam.2007.09.00818061252Search in Google Scholar

5. Marreto JA, Fontana RJ, Fu S. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J. Hepatol 2005; 42:218-22410.1016/j.jhep.2004.10.00515664247Open DOISearch in Google Scholar

6. El-Serag HB, TranT, Everhart JE. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.Gastroenterology 2004; 126: 460-46810.1053/j.gastro.2003.10.06514762783Search in Google Scholar

7. Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, Lin CJ et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000; 92:1152-116410.1093/jnci/92.14.1159Search in Google Scholar

8. Chen CH, Huang GT, Lee HS, Yang PM. Clinical impact of screening first - degree relatives of patients with hepatocellular carcinoma. J. Clin.Gastroenterology 1998; 27: 236-23910.1097/00004836-199810000-00011Search in Google Scholar

9. Donato F, Gelati V, Chiesa R, Albertini A, Bucella E, Boffetaa P, et al. A case control study on family history of liver cancer as a risk factor for hepatocellular carcinoma in North Italy. Brescia HCC Study Cancer Causes Control 1999; 10;417-42110.1023/A:1008989103809Search in Google Scholar

10. Zhu ZZ, Cong WH, et al. a p53 polymorphismmodifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection. Cancer 2005; 229:77-83.10.1016/j.canlet.2005.04.014Search in Google Scholar

11. Hang YM, Lu SC, Mato JMet al. Genetic polymorphisms in the methylentetrahydrofolate reductase and thymidylate syntethase genes and risk of hepatocellular carcinoma. Hepatology 2007; 46:749-75810.1002/hep.21735239124017659576Search in Google Scholar

12. Marrero JA, Fontane RJ, Lok As. NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology 2002; 36: 1349-135410.1002/hep.1840360609Open DOISearch in Google Scholar

13. Yu M W, Yang YC, Lin SM, et al. Androgen receptor exon 1 CAG repeats length and risk of hepatocellular carcinoma in women.Hepatology 2002; 36:156-163.10.1053/jhep.2002.3389712085360Search in Google Scholar

14. Kasugai H, Yamamoto R, Tatsuta M, et al. Value of heparinized fine-needle aspiration biopsy in liver malignancy. AJRAmJ Roentgenol 1985; 144:243-24410.2214/ajr.144.2.2432981458Search in Google Scholar

15. Peters RL. Pathology of hepatocellular carcinoma. In: Okuda K, Peters RL, eds. Hepatocellular carcinoma. New York: John Wiley, 1976:107-68Search in Google Scholar

16. Kondo F, Ebara M, Sugiura N, et al. Histological features and clinical course of large regenerative nodules: evaluation of their precancerous potentiality. Hepatology 1990; 12:592-810.1002/hep.18401203241698171Search in Google Scholar

17. Gibson JB, Sobin LH. Histological typing of tumors of the liver, biliary tract and pancreas. International histological classification of tumours no. 20. Geneva: World Health Organization, 1978:12-30Search in Google Scholar

18. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-48110.1080/01621459.1958.10501452Search in Google Scholar

19. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34:187-22010.1111/j.2517-6161.1972.tb00899.xSearch in Google Scholar

20. Trichopoulos D, MacMahon B, Sparros L, Merikas G. Smoking and hepatitis B-negative primary hepatocellular carcinoma. J Natl Cancer Inst 1980;65:111-114Search in Google Scholar

21. Oshima A, Tsukuma H, Hiyama T, Fujimoto I, Yamano H, Tanaka M. Follow-up study of HBs Ag-positive blood donors with special reference to effect of drinking and smoking on development of liver cancer. Int J Cancer 1984;34:775-77910.1002/ijc.29103406076511124Open DOISearch in Google Scholar

22. Tsukuma H, Hiyama T, Oshima A, et al. A case-control study of hepatocellular carcinoma in Osaka, Japan. Int J Cancer 1990;45:231-23610.1002/ijc.29104502052154409Open DOISearch in Google Scholar

23. Tanaka K, Hirohata T, Koga S, et al. Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res 1991;51:2842-2847Search in Google Scholar

24. Yu M-W, You S-L, Chang A-S, Lu S-N, Liaw Y-F, Chen C-J. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res 1991;51:5621-5625Search in Google Scholar

25. Hirayama T. A large-scale cohort study on the relationship between diet and selected cancers of digestive organs. In: Bruce WR, Correa P, Lipkin M, Tannenbaum SR, Wilkins TD, eds. Gastrointestinal cancer: endogenous factors. Banbury report 7. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1981:409-26.Search in Google Scholar

26. Shibata A, Hirohata T, Toshima H, Tashiro H. The role of drinking and cigarette smoking in the excess deaths from liver cancer. Jpn J Cancer Res 1986; 77:287-295Search in Google Scholar